Publications by authors named "Ayae Amemiya"
Rinsho Ketsueki
November 2017
Article Synopsis
- * She initially responded well to treatment with dasatinib, achieving a molecular response but continued to experience significant spleen enlargement (splenomegaly), confirmed by a bone marrow biopsy revealing myelofibrosis.
- * Following a lengthy treatment break from dasatinib, she began treatment with ruxolitinib, resulting in a reduction in spleen size after five months, suggesting a possible translocation event of BCR
View Article and Find Full Text PDF